Everolimus-eluting stents in interventional cardiology

References

• Coronary angioplasty versus medical therapy for angina: The second randomised intervention treatment of angina (RITA-2) trial. Rita-2 trial participantsLancet19973504614689274581
   PubMed Web of Science ®Google Scholar
• SerruysPWde JaegerePKiemeneijFA comparison of balloon-expandable- stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent study groupN Engl J Med19943314894958041413
   PubMed Web of Science ®Google Scholar
• MauriLHsiehWHMassaroJMHoKKD’AgostinoRCutlipDEStent thrombosis in randomized clinical trials of drug-eluting stentsN Engl J Med20073561020102917296821
   PubMed Web of Science ®Google Scholar
• LeonMBNikolskyECutlipDEImproved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease) trialJACC Cardiovasc Interv201031043105020965463
   PubMed Web of Science ®Google Scholar
• StoneGWMideiMNewmanWRandomized comparison of everolimus-eluting and paclitaxel-eluting stents: Two-year clinical follow-up from the clinical evaluation of the Xience V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions (SPIRIT) iii trialCirculation200911968068619171853
   PubMed Web of Science ®Google Scholar
• BodenWEO’RourkeRATeoKKOptimal medical therapy with or without PCI for stable coronary diseaseN Engl J Med20073561503151617387127
   PubMed Web of Science ®Google Scholar
• AgostoniPBiondi-ZoccaiGGGaspariniGLIs bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trialsEur Heart J20052688188915681573
   PubMed Web of Science ®Google Scholar
• FischmanDLLeonMBBaimDSA randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study InvestigatorsN Engl J Med19943314965018041414
   PubMed Web of Science ®Google Scholar
• BullerCEDzavikVCarereRGPrimary stenting versus balloon angioplasty in occluded coronary arteries: The Total Occlusion Study of Canada (TOSCA)Circulation199910023624210411846
   PubMed Web of Science ®Google Scholar
• CutlipDEChauhanMSBaimDSClinical restenosis after coronary stenting: Perspectives from multicenter clinical trialsJ Am Coll Cardiol2002402082208912505217
   PubMed Web of Science ®Google Scholar
• NayakAKKawamuraANestoRWMyocardial infarction as a presentation of clinical in-stent restenosisCirc J2006701026102916864936
   PubMed Web of Science ®Google Scholar
• MoriceMCSerruysPWSousaJEA randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizationN Engl J Med20023461773178012050336
   PubMed Web of Science ®Google Scholar
• MosesJWLeonMBPopmaJJSirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary arteryN Engl J Med20033491315132314523139
   PubMed Web of Science ®Google Scholar
• StoneGWEllisSGCoxDAA polymer-based, paclitaxel-eluting stent in patients with coronary artery diseaseN Engl J Med200435022123114724301
   PubMed Web of Science ®Google Scholar
• VezinaCKudelskiASehgalSNRapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principleJ Antibiot (Tokyo)1975287217261102508
   PubMed Web of Science ®Google Scholar
• AbdelmalekMFHumarAStickelFSirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: A randomized trialAm J Transplant20121269470522233522
   PubMed Web of Science ®Google Scholar
• ChanSTargeting the mammalian target of rapamycin (mTOR): A new approach to treating cancerBr J Cancer2004911420142415365568
   PubMed Web of Science ®Google Scholar
• GalloRPadureanAJayaramanTInhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycleCirculation1999992164217010217658
   PubMed Web of Science ®Google Scholar
• SousaJECostaMAAbizaidACSustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-upCirculation20011042007201111673337
   PubMed Web of Science ®Google Scholar
• SheibanIVillataGBollatiMSillanoDLotrionteMBiondi-ZoccaiGNext-generation drug-eluting stents in coronary artery disease: Focus on everolimus-eluting stent (Xience V)Vasc Health Risk Manag20084313818629361
   PubMedGoogle Scholar
• MoriceMCSerruysPWBarraganPLong-term clinical outcomes with sirolimus-eluting coronary stents: Five-year results of the RAVEL trialJ Am Coll Cardiol2007501299130417903626
   PubMed Web of Science ®Google Scholar
• WeiszGLeonMBHolmesDRJrFive-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (sirolimus-eluting stent in de-novo native coronary lesions) trialJ Am Coll Cardiol2009531488149719389558
   PubMed Web of Science ®Google Scholar
• LemosPASerruysPWvan DomburgRTUnrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world”: The rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registryCirculation200410919019514691037
   PubMed Web of Science ®Google Scholar
• SpauldingCHenryPTeigerESirolimus-eluting versus uncoated stents in acute myocardial infarctionN Engl J Med20063551093110416971716
   PubMed Web of Science ®Google Scholar
• AxelDIKunertWGoggelmannCPaclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug deliveryCirculation1997966366459244237
   PubMed Web of Science ®Google Scholar
• GrubeESilberSHauptmannKETaxus I: Six- and twelvemonth results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesionsCirculation2003107384212515740
   PubMed Web of Science ®Google Scholar
• ColomboADrzewieckiJBanningARandomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesionsCirculation200310878879412900339
   PubMed Web of Science ®Google Scholar
• StoneGWLanskyAJPocockSJPaclitaxel-eluting stents versus bare-metal stents in acute myocardial infarctionN Engl J Med20093601946195919420364
   PubMed Web of Science ®Google Scholar
• MoriceMCColomboAMeierBSirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: The REALITY trial: A randomized controlled trialJAMA200629589590416493102
   PubMed Web of Science ®Google Scholar
• WindeckerSRemondinoAEberliFRSirolimus-eluting and paclitaxel-eluting stents for coronary revascularizationN Engl J Med200535365366216105989
   PubMed Web of Science ®Google Scholar
• RaberLWohlwendLWiggerMFive-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: Results of the sirolimus-eluting versus paclitaxel-eluting stents for coronary revascularization late trialCirculation20111232819282821646500
   PubMed Web of Science ®Google Scholar
• GalloeAMThuesenLKelbaekHComparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: The SORT OUT II randomized trialJAMA200829940941618230778
   PubMed Web of Science ®Google Scholar
• WilliamsDOAbbottJDKipKEOutcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: Report of the DESCOVER RegistryCirculation20061142154216217060386
   PubMed Web of Science ®Google Scholar
• SimontonCABrodieBCheekBComparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: Results from a large prospective multicenter registry – STENT groupJ Am Coll Cardiol2007501214122217888837
   PubMed Web of Science ®Google Scholar
• OngATSerruysPWAokiJThe unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease in an unselected population: One-year results of the taxus-stent evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registryJ Am Coll Cardiol2005451135114115808774
   PubMed Web of Science ®Google Scholar
• DaemenJWenaweserPTsuchidaKEarly and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort studyLancet200736966767817321312
   PubMed Web of Science ®Google Scholar
• OngATMcFaddenEPRegarEde JaegerePPvan DomburgRTSerruysPWLate angiographic stent thrombosis (last) events with drug-eluting stentsJ Am Coll Cardiol2005452088209215963413
   PubMed Web of Science ®Google Scholar
• PfistererMBrunner-La RoccaHPBuserPTLate clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stentsJ Am Coll Cardiol2006482584259117174201
   PubMed Web of Science ®Google Scholar
• GuagliumiGSirbuVMusumeciGExamination of the in vivo mechanisms of late drug-eluting stent thrombosis findings from optical coherence tomography and intravascular ultrasound imagingJACC Cardiovasc Interv20125122022230145
   PubMed Web of Science ®Google Scholar
• JonerMFinnAVFarbAPathology of drug-eluting stents in humans: delayed healing and late thrombotic riskJ Am Coll Cardiol20064819320216814667
   PubMed Web of Science ®Google Scholar
• VirmaniRGuagliumiGFarbALocalized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious?Circulation200410970170514744976
   PubMed Web of Science ®Google Scholar
• JonerMNakazawaGFinnAVEndothelial cell recovery between comparator polymer-based drug-eluting stentsJ Am Coll Cardiol20085233334218652940
   PubMed Web of Science ®Google Scholar
• HansiCArabARzanyAAhrensIBodeCHehrleinCDifferences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfacesCatheter Cardiovasc Interv20097348849619235237
   PubMed Web of Science ®Google Scholar
• ChitkaraKPujaraKDrug-eluting stents in acute coronary syndrome: is there a risk of stent thrombosis with second-generation stents?Eur J Cardiovasc Med20101202421766004
   PubMedGoogle Scholar
• FajadetJWijnsWLaarmanGJRandomized, 1lind, multicenter study of the endeavor zotarolimus-eluting phosphorylcholine- encapsulated stent for treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trialCirculation200611479880616908773
   PubMed Web of Science ®Google Scholar
• LeonMBMauriLPopmaJJA randomized comparison of the endeavor zotarolimus-eluting stent versus the taxus paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trialJ Am Coll Cardiol20105554355420152559
   PubMed Web of Science ®Google Scholar
• KandzariDELeonMBPopmaJJComparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trialJ Am Coll Cardiol2006482440244717174180
   PubMed Web of Science ®Google Scholar
• RasmussenKMaengMKaltoftAEfficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): A randomised controlled superiority trialLancet20103751090109920231034
   PubMed Web of Science ®Google Scholar
• ParkDWKimYHYunSCComparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: The ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trialJ Am Coll Cardiol2010561187119520883925
   PubMed Web of Science ®Google Scholar
• GrubeESonodaSIkenoFSix- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymerCirculation20041092168217115123533
   PubMed Web of Science ®Google Scholar
• SerruysPWOngATPiekJJA randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: The SPIRIT FIRST trialEuroIntervention20051586519758878
   PubMedGoogle Scholar
• SerruysPWRuygrokPNeuznerJA randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: The SPIRIT II trialEuro Intervention2006228629419755303
   PubMedGoogle Scholar
• ClaessenBEBeijkMALegrandVTwo-year clinical, angiographic, and intravascular ultrasound follow-up of the Xience V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trialCirc Cardiovasc Interv2009233934720031737
   PubMed Web of Science ®Google Scholar
• StoneGWMideiMNewmanWComparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialJAMA20082991903191318430909
   PubMed Web of Science ®Google Scholar
• StoneGWRizviANewmanWEverolimus-eluting versus paclitaxel-eluting stents in coronary artery diseaseN Engl J Med20103621663167420445180
   PubMed Web of Science ®Google Scholar
• StoneGWRizviASudhirKRandomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (clinical evaluation of the Xience V everolimus eluting coronary stent system) IV trialJ Am Coll Cardiol201158192521514084
   PubMed Web of Science ®Google Scholar
• KedhiEJoesoefKSMcFaddenESecond-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): A randomised trialLancet201037520120920060578
   PubMed Web of Science ®Google Scholar
• SmitsPCKedhiERoyaardsKJ2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison Of The Everolimus Eluting Xience-V Stent With The Paclitaxel Eluting Taxus Liberte stent in all-comers: a randomized open label trial)J Am Coll Cardiol201158111821514083
   PubMed Web of Science ®Google Scholar
• OnumaYKukrejaNPiazzaNThe everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V stent evaluated at Rotterdam Cardiac Hospital) registryJ Am Coll Cardiol20095426927619589442
   PubMed Web of Science ®Google Scholar
• ParkKWChaeIHLimDSEverolimus-eluting versus sirolimus- eluting stents in patients undergoing percutaneous coronary intervention: The EXCELLENT (Efficacy of Xience/Promus versus Cypher to reduce late loss after stenting) randomized trialJ Am Coll Cardiol2011581844185422018294
   PubMed Web of Science ®Google Scholar
• SerruysPWSilberSGargSComparison of zotarolimus-eluting and everolimus-eluting coronary stentsN Engl J Med201036313614620554978
   PubMed Web of Science ®Google Scholar
• KastratiAMassbergSNdrepepaGIs diabetes the Achilles’ heel of limus-eluting stents?Circulation201112486987221859980
   PubMed Web of Science ®Google Scholar
• StettlerCAllemannSWandelSDrug eluting and bare metal stents in people with and without diabetes: Collaborative Network meta-analysisBMJ2008337a133118757996
   PubMed Web of Science ®Google Scholar
• KimWJLeeSWParkSWRandomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): Results from the ESSENCE-DIABETES trialCirculation201112488689221810659
   PubMed Web of Science ®Google Scholar
• StoneGWKedhiEKereiakesDJDifferential clinical responses to everolimus-eluting and paclitaxel-eluting coronary stents in patients with and without diabetes mellitusCirculation201112489390021824922
   PubMed Web of Science ®Google Scholar
• ValentiRMiglioriniASignoriniUImpact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusionEur Heart J2008292336234218682446
   PubMed Web of Science ®Google Scholar
• ValentiRVergaraRMiglioriniAComparison of everolimus- eluting stent with paclitaxel-eluting stent in long chronic total occlusionsAm J Cardiol20111071768177121529743
   PubMed Web of Science ®Google Scholar
• TamuraTKimuraTMorimotoTThree-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: The provisional side branch stenting approach versus the elective two-stent approachEuro Intervention2011758859621930463
   PubMed Web of Science ®Google Scholar
• LanskyAJYaqubMHermillerJBSide branch occlusion with everolimus-eluting and paclitaxel-eluting stents: Three-year results from the SPIRIT III randomised trialEuro Intervention20106Suppl JJ445221930490
   PubMed Web of Science ®Google Scholar
• BurzottaFTraniCTodaroDProspective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approachJACC Cardiovasc Interv2011432733521435612
   PubMed Web of Science ®Google Scholar
• HerradorJAFernandezJCGuzmanMAragonVComparison of zotarolimus- versus everolimus-eluting stents in the treatment of coronary bifurcation lesionsCatheter Cardiovasc Interv2011781086109221793165
   PubMed Web of Science ®Google Scholar
• StoneGWEllisSGO’ShaughnessyCDPaclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: The TAXUS V ISR randomized trialJAMA20062951253126316531618
   PubMed Web of Science ®Google Scholar
• HolmesDRJrTeirsteinPSatlerLSirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: The SISR randomized trialJAMA20062951264127316531619
   PubMed Web of Science ®Google Scholar
• AlmallaMSchroderJWProssVStegemannEMarxNHoffmannREverolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosisAm J Cardiol201110851852221624553
   PubMed Web of Science ®Google Scholar
• CannonLASimonDIKereiakesDThe Xience nano™ everolimus eluting coronary stent system for the treatment of small coronary arteries: The SPIRIT small vessel trialCatheter Cardiovasc Interv11252011
   Google Scholar
• StoneGWTeirsteinPSMeredithITA prospective, randomized evaluation of a novel everolimus-eluting coronary stent: The PLATINUM (a prospective, randomized, multicenter trial to assess an everolimus-eluting coronary stent system [Promus Element] for the treatment of up to two de novo coronary artery lesions) trialJ Am Coll Cardiol2011571700170821470815
   PubMed Web of Science ®Google Scholar
• SerruysPWOnumaYDudekDEvaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesJ Am Coll Cardiol2011581578158821958884
   PubMed Web of Science ®Google Scholar
• BakhaiAStoneGWMahoneyECost effectiveness of paclitaxel- eluting stents for patients undergoing percutaneous coronary revascularization: Results from the TAXUS-IV trialJ Am Coll Cardiol20064825326116843171
   PubMed Web of Science ®Google Scholar
• SchaferPESacrintyMTCohenDJCost-effectiveness of drug-eluting stents versus bare metal stents in clinical practiceCirc Cardiovasc Qual Outcomes2011440841521693724
   PubMed Web of Science ®Google Scholar
• EisensteinELLeonMBKandzariDELong-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the Cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (randomized controlled trial of the Medtronic Endeavor drug [ABT-578] eluting coronary stent system versus the Cypher sirolimus-eluting coronary stent system in de novo native coronary artery lesions)JACC Cardiovasc Interv200921199120720129546
   PubMed Web of Science ®Google Scholar
• LeonMBKandzariDEEisensteinELLate safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (randomized, controlled trial of the Medtronic Endeavor drug [ABT-578] eluting coronary stent system versus the Taxus paclitaxel-eluting coronary stent system in de novo native coronary artery lesions)JACC Cardiovasc Interv200921208121820129547
   PubMed Web of Science ®Google Scholar